Pharmacologic aspects of lung cancer chemotherapy.
A relatively small group of chemotherapeutic agents have gained widespread acceptance in the treatment of lung cancer. The pharmacologic properties of these agents are reviewed.
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002945:Cisplatin / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008727:Methotrexate / Q000494:pharmacology; D012597:Sclerosing Solutions / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000494:pharmacology
D000970:Antineoplastic Agents; D012597:Sclerosing Solutions; D014748:Vinca Alkaloids; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D008727:Methotrexate